| Financial Year |
March 31 2023 |
| Monetary Funds |
675,711,761.18 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
4,316,815.23 |
| Accounts Receivable |
486,238,802.03 |
| Advances to Suppliers |
61,697,611.33 |
| Other Receivables |
15,910,868.52 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
533,867,741.73 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
163,392,670.22 |
| Total Current Assets |
1,959,641,500.22 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
63,641,721.24 |
| Investment Properties |
-- |
| Fixed Assetes |
24,140,895.31 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
107,232,858.69 |
| R&D expenses |
16,601,588.47 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
4,457,276.12 |
| Deferred Income Tax Assets |
41,810,060.27 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
498,512,838.39 |
| Total Assets |
2,458,154,338.61 |
| Short-Term Loans |
280,660,388.89 |
| Trading Financial liabilities |
-- |
| Notes Payable |
44,199,022.18 |
| Accounts Payable |
358,743,061.17 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
16,508,124.09 |
| Taxes Payable |
9,241,182.86 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
20,384,597.55 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
67,221,954.18 |
| Other Current Liabilities |
29,582,930.05 |
| Sub-Total of Current Liabilities |
887,155,732.87 |
| Long-term Loans |
89,900,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
22,218,648.11 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
134,678,011.92 |
| Total Liabilities |
1,021,833,744.79 |
| Paid-In Capital(Or Share Stock) |
261,151,004.00 |
| Capital Surplus |
775,283,596.79 |
| Surplus Reserve |
22,421,269.95 |
| LESS:Treasury Stock |
56,604,514.37 |
| Undistributed Profits |
432,934,813.35 |
| Minority Stockholder's Interest |
661,313.50 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,435,659,280.32 |
| Owner's Equity（Stockholder's Equity） |
1,436,320,593.82 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,458,154,338.61 |
